Status: Not yet recruiting
Assessment of Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments
This study will evaluate the safety and performance of the Spatial StimeMD (SSMD) medical device in people with multiple sclerosis (MS). The SSMD device is intended to support patients through a non-invasive stimulation program. The study will assess changes in MS-related symptoms and physical function using clinical assessments and patient-reported outcomes.
Participants needed: 120
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Motion Informatics LTDUpdated: Feb 11, 2026Locations: 1
Eligibility criteria
Adult men and women aged 18-80 years. [+5]
Presence of contraindications to electrical stimulation (ES), including implante... [+7]